African Americans are less likely to have cirrhosis at the time of liver cancer diagnosis, but are more likely to have larger tumors and tumors that are poorly differentiated and have metastasized—differences that mean conventional hepatocellular carcinoma surveillance guidelines might inadvertently put them at a disadvantage, Mount Sinai researchers say.
